SYNLAB AG |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.34 EUR | -0.19% |
|
+0.19% | -9.46% |
| May. 08 | Transcript : SYNLAB AG, Q1 2024 Earnings Call, May 08, 2024 | |
| May. 08 | Laboratory chain Synlab starts the year with lower revenue | DP |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 2.86B 3.11B | Sales 2025 * | 3.02B 3.28B | Capitalization | 2.27B 2.47B |
|---|---|---|---|---|---|
| Net income 2024 * | 81M 87.95M | Net income 2025 * | 67M 72.75M | EV / Sales 2024 * | 1.31 x |
| Net Debt 2024 * | 1.47B 1.6B | Net Debt 2025 * | 1.64B 1.78B | EV / Sales 2025 * | 1.29 x |
| P/E ratio 2024 * |
27.9
x | P/E ratio 2025 * |
34.5
x | Employees | 23,538 |
| Yield 2024 * |
1.98% | Yield 2025 * |
1.98% | Free-Float | 14.22% |
More Fundamentals
* Assessed data
More news
Latest transcript on SYNLAB AG
More press releases
| 1 day | -0.19% | ||
| 1 week | +0.19% | ||
| Current month | -1.52% | ||
| 1 month | -3.00% | ||
| 3 months | -13.33% | ||
| 6 months | -2.54% | ||
| Current year | -9.46% |
1 week
10.20
10.44
1 month
10.2010.68
Current year
10.1012.43
1 year
8.0212.43
3 years
6.6825.00
5 years
6.6825.00
10 years
6.6825.00
| Managers | Title | Age | Since |
|---|---|---|---|
Mathieu Floreani
CEO | Chief Executive Officer | 56 | 21-01-25 |
Sami Badarani
DFI | Director of Finance/CFO | 61 | 21-01-25 |
Henrik Andreasen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
David Ebsworth
CHM | Chairman | 69 | 21-01-10 |
| Founder | 63 | 97-12-31 | |
Peter Catterall
BRD | Director/Board Member | 56 | 21-01-10 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.29% | 125 M€ | -.--% | ||
| 0.55% | 17 M€ | -.--% | - | |
| 0.18% | 18 M€ | +7.68% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-16 | 10.34 | -0.19% | 12,527 |
| 24-05-15 | 10.36 | +0.58% | 11,350 |
| 24-05-14 | 10.3 | +0.19% | 18,163 |
| 24-05-13 | 10.28 | +0.39% | 19,241 |
| 24-05-10 | 10.24 | -0.78% | 11,938 |
Delayed Quote Xetra, May 16, 2024 at 11:35 am EDT
More quotes
Synlab AG is a Germany based clinical laboratory and medical diagnostic services provider. The Company is engaged in laboratory services for human and veterinary medicine, as well as environmental analysis.
Calendar
07:00am
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
10.34
EUR
Average target price
14.5
EUR
Spread / Average Target
+40.23%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -9.46% | 2.47B | |
| -15.90% | 8.57B | |
| +65.60% | 4.3B | |
| -2.16% | 2.46B | |
| -44.11% | 2.31B | |
| -7.42% | 1.93B | |
| -18.68% | 1.53B | |
| -41.75% | 1.2B | |
| +11.31% | 1.14B | |
| +16.15% | 986M |
- Stock Market
- Equities
- SYAB Stock